Christine Simmons

9PUBLICATIONS
12CO-AUTHORS
Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|May 26, 2026
Guidance for Canadian Breast Cancer Practice: National Consensus Recommendations for the Systemic Treatment of Patients with Triple Negative Breast Cancer in Both the Early and Metastatic Setting 2025.

|Apr 27, 2026
Guidance for Canadian Breast Cancer Practice: National Consensus Recommendations for the Systemic Treatment of Patients with HER2+ Breast Cancer in Both the Early and Metastatic Settings (2025 Update).

|Apr 14, 2026
The Evolution of Targeted Therapies in Early Hormone Receptor-Positive, HER2-Negative Breast Cancer.

Hyejee Ohm, Caroline Lohrisch, Nathalie LeVasseur

|Feb 26, 2026
Guidance for Canadian Breast Cancer Practice: National Consensus Recommendations for the Systemic Treatment of Patients with HR+/HER2- Early Breast Cancer 2025.

Sandeep Sehdev, Anil Abraham Joy, Jean-François Boileau

|Feb 26, 2026
Guidance for Canadian Breast Cancer Practice: National Consensus Recommendations for the Systemic Treatment of Patients with HR+/HER2- Metastatic Breast Cancer 2025.

Katarzyna J Jerzak, Aalok Kumar, Jean-François Boileau

|Jun 16, 2023
Targeting HER2-low in metastatic breast cancer: an evolving treatment paradigm.

Charlie Yang, Christine Brezden-Masley, Anil Abraham Joy

Pageof 2

Frequent Collaborators

5 joint publications

Anil Abraham Joy

5 joint publications

Christine Brezden-Masley

5 joint publications

Sandeep Sehdev

5 joint publications

Nathalie LeVasseur